Old Mission Capital’s Cytokinetics CYTK Stock Holding History

Old Mission Capital’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,031	Closed	-$239K	–	544
2020 Q3	$239K	Buy	+11,031	New	+$258K	0.02%	372

Other funds holding CYTK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Old Mission Capital's CYTK Position: Q4 2020 in Review

Old Mission Capital sold out of Cytokinetics (CYTK) in Q4 2020, closing a stake of 11,031 shares — an estimated $239K sold.

Old Mission Capital first reported a position in CYTK in Q3 2020 and held it in 1 quarter. The position peaked at $239K in Q3 2020. 178 funds tracked by Wall St. Rank hold CYTK as of Q4 2020.

Old Mission Capital reported no remaining Cytokinetics position as of Q4 2020 after selling out during the quarter.
Old Mission Capital sold 11,031 Cytokinetics shares in Q4 2020, an estimated $239K.
Old Mission Capital first reported a position in Cytokinetics in Q3 2020 and held it in 1 quarter.
Old Mission Capital's Cytokinetics position peaked at $239K in Q3 2020.
178 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2020.

Based on Old Mission Capital's 13F filing for Q4 2020, filed 17 Feb 2021.